PL347542A1 - Therapeutic product and its use - Google Patents
Therapeutic product and its useInfo
- Publication number
- PL347542A1 PL347542A1 PL99347542A PL34754299A PL347542A1 PL 347542 A1 PL347542 A1 PL 347542A1 PL 99347542 A PL99347542 A PL 99347542A PL 34754299 A PL34754299 A PL 34754299A PL 347542 A1 PL347542 A1 PL 347542A1
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic product
- therapeutic
- product
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9826536.6A GB9826536D0 (en) | 1998-12-02 | 1998-12-02 | Therapeutic product and its use |
| GBGB9826537.4A GB9826537D0 (en) | 1998-12-02 | 1998-12-02 | Therapeutic product and its use |
| GBGB9826535.8A GB9826535D0 (en) | 1998-12-02 | 1998-12-02 | Therapeutic product and its use |
| PCT/GB1999/004021 WO2000032558A1 (en) | 1998-12-02 | 1999-12-02 | Therapeutic product and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL347542A1 true PL347542A1 (en) | 2002-04-08 |
Family
ID=27269570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99347542A PL347542A1 (en) | 1998-12-02 | 1999-12-02 | Therapeutic product and its use |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1135361A1 (en) |
| JP (1) | JP2002531431A (en) |
| KR (1) | KR20010080364A (en) |
| CN (1) | CN1329590A (en) |
| AU (1) | AU1400100A (en) |
| BR (1) | BR9915873A (en) |
| CA (1) | CA2350635A1 (en) |
| HU (1) | HUP0104420A2 (en) |
| IL (1) | IL142778A0 (en) |
| NO (1) | NO20012738D0 (en) |
| PL (1) | PL347542A1 (en) |
| WO (1) | WO2000032558A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001034125A2 (en) * | 1999-11-09 | 2001-05-17 | Darwin Discovery Limited | Therapeutic use and formulation of (-)-tramadol |
| BR0114395A (en) * | 2000-10-03 | 2005-08-16 | Penwest Pharmaceuticals Compan | Pharmaceutical composition for oral supply administration |
| DE10108122A1 (en) * | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Medicines based on tramadol |
| AU2002364517A1 (en) | 2001-11-30 | 2003-06-17 | Sepracor Inc. | Tramadol analogs and uses thereof |
| RU2008113439A (en) | 2005-09-09 | 2009-10-20 | Лабофарм Инк. (CA) | COMPOSITIONS WITH SLOW DELIVERY OF A MEDICINAL PRODUCT |
| SG178775A1 (en) | 2007-02-12 | 2012-03-29 | Dmi Biosciences Inc | Reducing side effects of tramadol |
| CN101686672A (en) * | 2007-05-31 | 2010-03-31 | 塞普拉柯公司 | Phenyl substituted cycloalkamines as monoamine reuptake inhibitors |
| JOP20190251A1 (en) | 2017-05-31 | 2019-10-21 | Metys Pharmaceuticals AG | Synergistic compositions comprising (r)-dimiracetam (1) and (s)-dimiracetam (2) in a non-racemic ratio |
| US10377708B2 (en) | 2017-12-05 | 2019-08-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| CN118593482A (en) | 2017-12-05 | 2024-09-06 | 赛诺维信制药公司 | Non-racemic mixture and its use |
| AU2019394706A1 (en) * | 2018-12-04 | 2021-05-20 | Metys Pharmaceuticals AG | Synergistic compositions comprising R-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones and S-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2H)-ones in a non-racemic ratio |
| JP2022535893A (en) | 2019-06-04 | 2022-08-10 | サノビオン ファーマシューティカルズ インク | MODIFIED RELEASE FORMULATIONS AND THEIR USE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204116A (en) * | 1991-05-01 | 1993-04-20 | Alza Corporation | Dosage form providing immediate therapy followed by prolonged therapy |
| AU741821B2 (en) * | 1997-03-11 | 2001-12-13 | Arakis Limited | Dosage forms comprising separate portions of R- and S-enantiomers |
| DE19807535A1 (en) * | 1998-02-21 | 1999-08-26 | Asta Medica Ag | Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying |
-
1999
- 1999-12-02 CN CN99813934A patent/CN1329590A/en active Pending
- 1999-12-02 WO PCT/GB1999/004021 patent/WO2000032558A1/en not_active Ceased
- 1999-12-02 EP EP99973016A patent/EP1135361A1/en not_active Withdrawn
- 1999-12-02 CA CA002350635A patent/CA2350635A1/en not_active Abandoned
- 1999-12-02 AU AU14001/00A patent/AU1400100A/en not_active Abandoned
- 1999-12-02 KR KR1020017005443A patent/KR20010080364A/en not_active Withdrawn
- 1999-12-02 HU HU0104420A patent/HUP0104420A2/en unknown
- 1999-12-02 BR BR9915873-6A patent/BR9915873A/en not_active IP Right Cessation
- 1999-12-02 PL PL99347542A patent/PL347542A1/en not_active Application Discontinuation
- 1999-12-02 JP JP2000585200A patent/JP2002531431A/en active Pending
- 1999-12-02 IL IL14277899A patent/IL142778A0/en unknown
-
2001
- 2001-06-01 NO NO20012738A patent/NO20012738D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20012738L (en) | 2001-06-01 |
| CN1329590A (en) | 2002-01-02 |
| KR20010080364A (en) | 2001-08-22 |
| NO20012738D0 (en) | 2001-06-01 |
| CA2350635A1 (en) | 2000-06-08 |
| BR9915873A (en) | 2001-08-21 |
| HUP0104420A2 (en) | 2002-08-28 |
| WO2000032558A1 (en) | 2000-06-08 |
| JP2002531431A (en) | 2002-09-24 |
| EP1135361A1 (en) | 2001-09-26 |
| AU1400100A (en) | 2000-06-19 |
| IL142778A0 (en) | 2002-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9415125D0 (en) | Surgical product and its use | |
| PL335555A1 (en) | Novel compounds - substituted benzamides and therapeutic agent | |
| IL142778A0 (en) | Therapeutic product and its use | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
| GB9615435D0 (en) | Spray-dried product and its therapeutic use | |
| GB9810920D0 (en) | Therapeutic use | |
| GB9816897D0 (en) | Therapeutic use | |
| GB9812662D0 (en) | Therapeutic use | |
| GB9616504D0 (en) | Therapeutic product and its use | |
| GB9826536D0 (en) | Therapeutic product and its use | |
| GB9826535D0 (en) | Therapeutic product and its use | |
| GB9826537D0 (en) | Therapeutic product and its use | |
| GB9826539D0 (en) | Therapeutic product and its use | |
| GB9821179D0 (en) | Therapeutic use | |
| GB9811624D0 (en) | Therapeutic use | |
| GB9929581D0 (en) | Comjpositions and their use | |
| HK1038003A (en) | Therapeutic product and its use | |
| GB9616508D0 (en) | Therapeutic product and its use | |
| GB9616507D0 (en) | Therapeutic product and its use | |
| GB9616510D0 (en) | Therapeutic product and its use | |
| GB9616503D0 (en) | Therapeutic product and its use | |
| GB9616509D0 (en) | Therapeutic product and its use | |
| GB9616506D0 (en) | Therapeutic product and its use | |
| GB9616505D0 (en) | Therapeutic product and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |